- Report
- December 2024
- 150 Pages
Global
From €3052EUR$3,358USD£2,591GBP
€3590EUR$3,950USD£3,049GBP
- Report
- October 2024
- 186 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 199 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 195 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- August 2024
- 141 Pages
Global
From €2726EUR$2,999USD£2,315GBP
- Report
- May 2024
- 180 Pages
Global
From €4090EUR$4,500USD£3,473GBP
- Report
- September 2020
- 40 Pages
China
From €2181EUR$2,400USD£1,852GBP
- Report
- November 2023
- 150 Pages
Global
From €4408EUR$4,850USD£3,743GBP
- Report
- August 2022
Global
From €4090EUR$4,500USD£3,473GBP
- Report
- December 2023
- 143 Pages
Global
From €4045EUR$4,450USD£3,435GBP
- Report
- September 2022
- 114 Pages
Global
From €4090EUR$4,500USD£3,473GBP
- Report
- February 2024
- 115 Pages
Global
From €4317EUR$4,750USD£3,666GBP
- Report
- November 2023
- 117 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- November 2023
- 108 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- November 2023
- 95 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- June 2022
- 198 Pages
Global
From €2199EUR$2,419USD£1,867GBP
€3141EUR$3,456USD£2,667GBP

The Recombinant Coagulation Factors market is a subset of the Hematological Drugs market, which includes drugs used to treat blood-related diseases. Recombinant Coagulation Factors are proteins used to treat bleeding disorders, such as hemophilia, von Willebrand disease, and other rare bleeding disorders. These drugs are used to replace or supplement the body's natural clotting factors, which are proteins that help the blood clot. Recombinant Coagulation Factors are produced in a laboratory using recombinant DNA technology, which allows for the production of large quantities of the proteins.
The Recombinant Coagulation Factors market is highly competitive, with several major players. These include Novo Nordisk, Pfizer, Bayer, Biogen, and CSL Behring. Show Less Read more